PS1157 EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL
Ghia, P., Flinn, I., Lamanna, N., Montillo, M., Illés, Ã., Etienne, G., Delgado, J., Kuss, B., Tam, C., Offner, F., Bosch, F., Davids, M., Jäger, U., Cymbalista, F., Weaver, D., Lustgarten, S., YouVolume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000562912.80861.b2
Date:
June, 2019
File:
PDF, 488 KB
2019